BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 68743)

  • 1. Fate of DNA and its complexes with daunorubicin and adriamycin in rat fibroblasts [proceedings].
    Noël G; Trouet A
    Arch Int Physiol Biochim; 1977 Feb; 85(1):189-9. PubMed ID: 68743
    [No Abstract]   [Full Text] [Related]  

  • 2. Transport and storage of daunorubicin and doxorubicin in cultured fibroblasts.
    Peterson C; Trouet A
    Cancer Res; 1978 Dec; 38(12):4645-9. PubMed ID: 719643
    [No Abstract]   [Full Text] [Related]  

  • 3. Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts.
    Noel G; Peterson C; Trouet A; Tulkens P
    Eur J Cancer (1965); 1978 Apr; 14(4):363-8. PubMed ID: 648557
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
    Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA-binding characteristics of aclarubicin as compared with daunorubicin and doxorubicin.
    Ando S; Kamiya K; Yoshimura T; Tsutani H; Ueda T; Uchida M; Nakamura T; Uchino H
    Anticancer Res; 1988; 8(3):409-15. PubMed ID: 3164610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of new derivatives of daunorubicin and adriamycin with DNA.
    Arlandini E; Vigevani A; Arcamone F
    Farmaco Sci; 1977 May; 32(5):315-23. PubMed ID: 862886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of the daunorubicin-DNA complex in cultured fibroblasts.
    Peterson C; Noël G; Zenebergh A; Trouet A
    Cancer Chemother Pharmacol; 1979; 2(1):3-6. PubMed ID: 498416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between effects on nucleic acid synthesis in cell cultures and cytotoxicity of 4-demethoxy derivatives of daunorubicin and adriamycin.
    Supino R; Necco A; Dasdia T; Casazza AM; Di Marco A
    Cancer Res; 1977 Dec; 37(12):4523-8. PubMed ID: 922737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic activation and binding of adriamycin to nuclear DNA.
    Sinha BK; Trush MA; Kennedy KA; Mimnaugh EG
    Cancer Res; 1984 Jul; 44(7):2892-6. PubMed ID: 6327028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Daunomycin and adriamycin antitumor cell antibody conjugates.
    Hurwitz E; Levy R; Maron R
    Isr J Med Sci; 1975 Dec; 11(12):1396. PubMed ID: 1218993
    [No Abstract]   [Full Text] [Related]  

  • 11. A hypothesis concerning possible new derivatives of daunorubicin and adriamycin with enhanced DNA-binding properties.
    Neidle S
    Cancer Treat Rep; 1977 Aug; 61(5):928-9. PubMed ID: 890699
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuous mixing experiments allow to determine the size of binding sites for anthracyclines complexed to DNA.
    Walter A
    Biomed Biochim Acta; 1985; 44(9):1321-7. PubMed ID: 3866577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular pharmacology of N,N-dimethyl daunorubicin and N,N-dimethyl adriamycin.
    Egorin MJ; Clawson RE; Ross LA; Bachur NR
    Cancer Res; 1980 Jun; 40(6):1928-33. PubMed ID: 7371027
    [No Abstract]   [Full Text] [Related]  

  • 14. The interaction of daunorubicin and doxorubicin with DNA and chromatin.
    Zunino F; Di Marco A; Zaccara A; Gambetta RA
    Biochim Biophys Acta; 1980 Apr; 607(2):206-14. PubMed ID: 7370266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between activity and amino sugar stereochemistry of daunorubicin and adriamycin derivatives.
    Di Marco A; Casazza AM; Gambetta R; Supino R; Zunino F
    Cancer Res; 1976 Jun; 36(6):1962-6. PubMed ID: 773533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-binding parameters of daunorubicin and doxorubicin in the conditions used for studying the interaction of anthracycline-DNA complexes with cells in vitro.
    Schneider YJ; Baurain R; Zenebergh A; Trouet A
    Cancer Chemother Pharmacol; 1979; 2(1):7-10. PubMed ID: 498422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative uptake of adriamycin and daunorubicin in sensitive and resistant friend leukemia cells measured by flow cytometry.
    Tapiero H; Fourcade A; Vaigot P; Farhi JJ
    Cytometry; 1982 Mar; 2(5):298-302. PubMed ID: 6951693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proceedings: Binding of DNA to the nuclear membrane in growing and resting 3T3-cells].
    Freienstein CM; Freitag H; Süss R
    Verh Dtsch Ges Pathol; 1973; 57():406. PubMed ID: 4142246
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Digoxin does not prevent daunorubicin or adriamycin from binding to rat heart muscle.
    Smith BJ; Kundv D
    Br J Cancer; 1976 Feb; 33(2):232-3. PubMed ID: 1259917
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytotoxic effects of the lysosomotropic agents DNA-ellipticine, DNA-daunorubicin, and DNA-ellipticine:daunorubicin on L1210 leukemia cells.
    Sorace RA; Sheid B
    Cancer Treat Rep; 1979 Jan; 63(1):43-51. PubMed ID: 421232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.